HL Deb 16 January 2003 vol 643 cc58-9WA
Lord Morris of Manchester

asked Her Majesty's Government:

What representations they are considering on the Market Research Bureau's recent finding that the United Kingdom has the lowest availability of recombinant for people with haemophilia in the developed world; and whether they will be taking any action. [HL934]

The Parliamentary Under-Secretary of State, Department of Health (Lord Hunt of Kings Heath)

These findings have been drawn to the Government's attention by the Haemophilia Society and the All Party Parliamentary Group on Haemophilia.

In England, all haemophilia patients up to the age of 21 years receive recombinant clotting factors. The Government are considering the case for extending provision to all other haemophilia patients. A decision will be made shortly.